AU2961499A - Obesity preventives - Google Patents

Obesity preventives

Info

Publication number
AU2961499A
AU2961499A AU29614/99A AU2961499A AU2961499A AU 2961499 A AU2961499 A AU 2961499A AU 29614/99 A AU29614/99 A AU 29614/99A AU 2961499 A AU2961499 A AU 2961499A AU 2961499 A AU2961499 A AU 2961499A
Authority
AU
Australia
Prior art keywords
preventives
obesity
obesity preventives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29614/99A
Inventor
Kazumi Osada
Kenji Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU2961499A publication Critical patent/AU2961499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
AU29614/99A 1997-10-08 1999-04-02 Obesity preventives Abandoned AU2961499A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9276089A JPH11116478A (en) 1997-10-08 1997-10-08 Preventing agent for obesity
PCT/JP1999/001748 WO2000059507A1 (en) 1997-10-08 1999-04-02 Obesity preventives

Publications (1)

Publication Number Publication Date
AU2961499A true AU2961499A (en) 2000-10-23

Family

ID=26440117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29614/99A Abandoned AU2961499A (en) 1997-10-08 1999-04-02 Obesity preventives

Country Status (3)

Country Link
JP (1) JPH11116478A (en)
AU (1) AU2961499A (en)
WO (1) WO2000059507A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846053B2 (en) * 2008-09-26 2014-09-30 Sdg, Inc. Orally bioavailable lipid-based constructs
US9145453B2 (en) * 2007-09-28 2015-09-29 Sdg, Inc. Orally bioavailable lipid-based constructs
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US20100080773A1 (en) 2008-09-26 2010-04-01 Sdg, Inc. Orally Bioavailable Lipid-Based Constructs
WO2018169954A1 (en) 2017-03-13 2018-09-20 Sdg, Inc. Lipid-based nanoparticles with enhanced stability
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05192090A (en) * 1991-12-04 1993-08-03 Norin Suisansyo Kyushu Nogyo Shikenjo Method for feeding vitamin b group to monogastric animals
JPH0995448A (en) * 1995-09-29 1997-04-08 Calpis Food Ind Co Ltd:The Increase in biotin concentration in blood and biotin-containing beverage or food product

Also Published As

Publication number Publication date
JPH11116478A (en) 1999-04-27
WO2000059507A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU6181298A (en) Combination mechanical rotator-rocker
AU6827898A (en) Detergent-package combination
AU5272198A (en) EMP-charge-eliminator
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU6185898A (en) Clavaspirins
AU7761998A (en) Korrosionsschutzanstrichstoff
AU2961499A (en) Obesity preventives
AU8214598A (en) 3-benzylpiperidine
AU4469997A (en) Heregulin-gamma
AU5391798A (en) Thiamacrolides
AU8991998A (en) Renovative pipeliner
AU9183798A (en) Catamaran - bicycle - kayak
AU9732798A (en) Gearwheel
AU5540298A (en) Rockbolts
AU6060598A (en) Multi-hopper
AU8121298A (en) G-seat
AU6507298A (en) Renovative pipeliner
AU6237398A (en) N-het-substituted glycerophosphoethanolamines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase